http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_364363e65129b7d3052c992d11cc4740
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Stål |
| name | Olle Stål |
| given-name | Olle |
| organization-name | Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden 2Department of Clinical and Experimental Medicine, and Department of Oncology, Linköping University, Linköping, Sweden. Department of Biomedical and Clinical Sciences and Department of Oncology Linköping University Linköping Sweden Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden7Department of Oncology, Linköping University, Linköping, Sweden Maria Ekholm, Pär-Ola Bendahl, Mårten Fernö, and Lisa Rydén, Lund University, Lund; Maria Ekholm, Ryhov County Hospital, Jönköping; and Bo Nordenskjöld and Olle Stål, Linköping University, Linköping, Sweden. Department of Biomedical and Clinical Sciences Linköping University Linköping Sweden; Department of Oncology Linköping University Linköping Sweden Department of Clinical and Experimental Medicine and Department of Oncology, Faculty of Health Sciences, Linköping University, Linköping, Sweden Authors' Affiliations: 1bioTheranostics, Inc., San Diego, California; 2Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 3Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 4Department of Oncology, Karolinska University Hospital, Karolinska Institute, Stockholm; 5Department of Clinical and Experimental Medicine, Linköping University; and 6Department of Oncology, County Council of Östergötland, Linköping, Sweden; Authors' Affiliations: 1bioTheranostics, Inc., San Diego, California; 2Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 3Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 4Department of Oncology, Karolinska University Hospital, Karolinska Institute, Stockholm; 5Department of Clinical and Experimental Medicine, Linköping University; and 6Department of Oncology, County Council of Östergötland, Linköping, Sweden Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, Linköping, Sweden Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Linköping, Sweden 3Department of Clinical and Experimental Medicine, Institution of Surgery and Clinical Oncology, Linköpings Universitet, Linköping, Sweden. Authors' Affiliations: 1Division of Surgery and Clinical Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden; and Departments of 2Cytology and 3Oncology, Karolinska University Hospital, Stockholm, Sweden Department of Clinical and Experimental Medicine Oncology, Linköping University Linköping Sweden Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; From the Department of Surgery, Helsingborgs Lasarett, Helsingborg; Department of Laboratory Medicine, Pathology, University Hospital, Malmö; Department of Oncology, University Hospital, Lund; Department of Oncology, University Hospital, Linköping; Department of Pathology and Cytology, Kalmar County Hospital, Kalmar; and South Swedish and Southeast Swedish Breast Cancer Groups, Sweden Department of Biomedical and Clinical Sciences and Department of Oncology, Linköping University, 581 83 Linköping, Sweden Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Department of Oncology, Linköping University, Linköping, Sweden Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Oncology, Linköping University, Linköping, Sweden |
Incoming Links
Total number of triples: 135.